Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $527.3500 (-2.84%) ($520.2900 - $549.9900) on Wed. Sep. 9, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.37% (three month average) | RSI | 42 | Latest Price | $527.3500(-2.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.2% a day on average for past five trading days. | Weekly Trend | REGN declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(66%) XLV(53%) XBI(50%) QQQ(43%) IWF(42%) | Factors Impacting REGN price | REGN will decline at least -1.185% in a week (0% probabilities). VIXM(-16%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.185% (StdDev 2.37%) | Hourly BBV | 0 () | Intraday Trend | -4% | | | |
|
1 - 5 Day Possible Target | $523.57(-0.72%) | Resistance Level | $535.67 | 5 Day Moving Average | $519.48(1.51%) | 10 Day Moving Average | $521.51(1.12%) | 20 Day Moving Average | $535.67(-1.55%) | To recent high | -11% | To recent low | 7.1% | Market Cap | $55.914b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |